Coherus BioSciences Inc
For the period ended Mar 31, 2024. Filed May 9, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 9, 2024
CHRS$0.82+6.2%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Table of Contents
| · · Page | |||
|---|---|---|---|
| | CAUTIONARY NOTE REGARDING FORWARD LOOKING STATEMENTS | | 3 |
| PART I | FINANCIAL INFORMATION | | 5 |
| ITEM 1 | Unaudited Condensed Consolidated Financial Statements | | 5 |
| Condensed Consolidated Balance Sheets | | 5 | |
| | Condensed Consolidated Statements of Operations | | 6 |
| | Condensed Consolidated Statements of Comprehensive Income (Loss) | | 7 |
| | Condensed Consolidated Statements of Stockholders’ Deficit | | 8 |
| | Condensed Consolidated Statements of Cash Flows | | 9 |
| | Notes to Condensed Consolidated Financial Statements | | 10 |
| ITEM 2 | Management’s Discussion and Analysis of Financial Condition and Results of Operations | | 35 |
| ITEM 3 | Quantitative and Qualitative Disclosure About Market Risk | | 50 |
| ITEM 4 | Controls and Procedures | | 51 |
| PART II | OTHER INFORMATION | | 52 |
| ITEM 1. | Legal Proceedings | | 52 |
| ITEM 1A. | Risk Factors | | 52 |
| ITEM 2 | Unregistered Sales of Equity Securities and Use of Proceeds, and Issuer Purchases of Equity Securities | | 109 |
| ITEM 3 | Defaults Upon Senior Securities | | 109 |
| ITEM 4 | Mine Safety Disclosures | | 109 |
| ITEM 5 | Other Information | | 109 |
| ITEM 6. | Exhibits | | 109 |
| | | | |
| Exhibit Index | | 110 | |
| Signatures | | 112 | |
| UDENYCA®, UDENYCA® ONBODY™, YUSIMRY® and LOQTORZI®, whether or not appearing in large print or with the trademark symbol, are trademarks of Coherus, its affiliates, related companies or its licensors or joint venture partners, unless otherwise noted. Trademarks and trade names of other companies appearing in this Quarterly Report on Form 10-Q are, to the knowledge of Coherus, the property of their respective owners. | | | |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.